What’s new in breast pathology 2022: WHO 5th edition and biomarker updates
- Author:
Kristen MULLER
1
;
Julie M. JORNS
;
Gary TOZBIKIAN
Author Information
- Publication Type:Newsletter
- From:Journal of Pathology and Translational Medicine 2022;56(3):170-171
- CountryRepublic of Korea
- Language:English
- Abstract: The 5th edition WHO Classification of Breast Tumours (2019) has introduced changes to our practices. Highlights are presented below, with a focus on modifications to morphological subtype categorization. In addition, we summarize important updates to ER and PR testing made in the 2020 ASCO/CAP guidelines, and briefly discuss PD-L1 and Ki-67 testing in breast cancer.
